The estimated Net Worth of James R Glynn is at least $81.8 Tausend dollars as of 4 August 2009. James Glynn owns over 15,000 units of Alphatec Inc stock worth over $81,750 and over the last 17 years James sold ATEC stock worth over $0.
James has made over 2 trades of the Alphatec Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently James bought 15,000 units of ATEC stock worth $52,350 on 4 August 2009.
The largest trade James's ever made was buying 15,000 units of Alphatec Inc stock on 4 August 2009 worth over $52,350. On average, James trades about 2,727 units every 25 days since 2007. As of 4 August 2009 James still owns at least 15,000 units of Alphatec Inc stock.
You can see the complete history of James Glynn stock trades at the bottom of the page.
James's mailing address filed with the SEC is 1600 FARADAY AVENUE, , CARLSBAD, CA, 92008.
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster und Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Alphatec Inc executives and other stock owners filed with the SEC include: